ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

BVS Bioventus Inc

3.97
0.00 (0.00%)
Pre Mercado
Última actualización: 03:05:54
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Bioventus Inc BVS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 3.97 03:05:54
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.97
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202406:30GLOBEBioventus to Report First Quarter of Fiscal Year 2024..
12/3/202406:30GLOBEBioventus Announces Fourth Quarter and Full Year 2023..
04/3/202407:00GLOBEBioventus to Report Fourth Quarter of Fiscal Year 2023..
06/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
22/1/202415:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202407:27EDGAR2Form 8-K - Current report
18/1/202415:15GLOBEBioventus Enters into an Amendment with its Credit Agreement..
12/1/202416:10EDGAR2Form 8-K - Current report
12/1/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202415:39EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/1/202415:15GLOBEBioventus Announces Inducement Equity to President and Chief..
09/1/202407:55EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/12/202307:00EDGAR2Form 8-K - Current report
19/12/202315:30GLOBEBioventus Names Robert Claypoole as President and Chief..
06/12/202307:00GLOBEBioventus Agrees to Nationwide Contract with Aetna™ Medicare..
07/11/202306:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:35EDGAR2Form 8-K - Current report
07/11/202306:00GLOBEBioventus Reports Third Quarter Financial Results; Raises..
31/10/202306:00GLOBEBioventus to Report Third Quarter of Fiscal Year 2023..
19/9/202320:52GLOBEBioventus to Present at the Cantor Global Healthcare..
06/9/202315:30GLOBEBioventus to Present at the Morgan Stanley 21st Annual..
08/8/202307:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202307:02EDGAR2Form 8-K - Current report
08/8/202306:30GLOBEBioventus Reports Second Quarter Financial Results;..
04/8/202307:30GLOBEBioventus to Present at the Canaccord Genuity 43rd Annual..
01/8/202316:35GLOBEBioventus to Report Second Quarter of Fiscal Year 2023..
23/5/202306:30GLOBEBioventus Completes Divestiture of its Wound Business
16/5/202315:15GLOBEBioventus Reports First Quarter Financial Results
15/5/202316:33GLOBEBioventus Reschedules Reporting of First Quarter Fiscal Year..
11/5/202306:00GLOBEBioventus Reschedules Earnings Call to May 16, 2023; Files..
10/5/202308:00GLOBEBioventus Announces Divestiture of its Wound Business

Su Consulta Reciente

Delayed Upgrade Clock